MYC and central nervous system cancer: These results suggested that MYH9 promotes c-Myc pathway activation via USP14-mediated deubiquitination of NAP1L1, providing a novel mechanism by which MYH9 regulates protein expression related to the proliferation and temozolomide resistance of glioma cells.